Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses.
about
Glucosamine therapy for treating osteoarthritisGlucosamine increases hyaluronic acid production in human osteoarthritic synovium explants10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furinThe human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination.N-acetylglucosamine: production and applicationsRole of glucosamine in the treatment for osteoarthritisThe effects of three-month oral supplementation with a nutraceutical and exercise on the locomotor pattern of aged horses.Glucosamine supplementation after anterior cruciate ligament reconstruction in athletes: a randomized placebo-controlled trial.A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individualsPhysiological effects of oral glucosamine on joint health: current status and consensus on future research prioritiesEffects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty AcidsExogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1beta.The repair of full-thickness articular cartilage defect using intra-articular administration of N-acetyl-D-glucosamine in the rabbit knee: randomized controlled trialThe reverse glucosamine sulfate pathway: application in knee osteoarthritis.Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental studyInflammation and arthritis: perspectives of the glycobiologist.Disc size markedly influences concentration profiles of intravenously administered solutes in the intervertebral disc: a computational study on glucosamine as a model solute.Influence of oral glucosamine supplementation in young horses challenged with intra-articular lipopolysaccharide.Effect of glucosamine on intraocular pressure: a randomized clinical trial.Effects of oral glucosamine hydrochloride administration on plasma free amino acid concentrations in dogs.The gastrointestinal microbiome and musculoskeletal diseases: a beneficial role for probiotics and prebiotics.Metabolomic analyses of blood plasma after oral administration of D-glucosamine hydrochloride to dogs.Precolumn derivatization LC-MS/MS method for the determination and pharmacokinetic study of glucosamine in human plasma and urine.Anti-inflammatory effects in a mouse osteoarthritis model of a mixture of glucosamine and chitooligosaccharides produced by bi-enzyme single-step hydrolysis.Glucosamine protects nucleus pulposus cells and induces autophagy via the mTOR-dependent pathway.Human Articular Cartilage Proteoglycans Are Not Undersulfated in Osteoarthritis
P2860
Q24244026-A4ECBB55-C5A7-41A9-9C00-CCD268FD98B6Q33368886-44959941-E71A-494F-8050-A61B01B71CA6Q33678954-D7B43C39-0E73-4BFE-A3EC-955B4FCFC666Q33679221-078134EB-DEF1-4552-BF87-7851D93B4930Q34191432-1380CE68-5C6F-494A-ADCF-D4E1A880EBEEQ34264613-E7764C8A-7393-4215-8CB2-0675B056D596Q34369140-F43C6C18-3DCF-4962-83A2-C6ABD9434FC2Q34460174-9334CB06-728C-477D-8AC0-B039C5AB6A24Q34588403-EC058AD0-9DCB-4F56-8197-670A396B6880Q34636799-B7B33F7D-EA3C-4DE1-B129-F4904018EB0FQ35147261-C43DFDCC-7D0E-4561-8AB5-59A8CA59DD6EQ35630056-25654065-7938-4ADF-B948-A5A0CEC178D0Q36298442-C1FBC4C7-C206-46B0-B1DD-5880D1EF6F88Q36719696-CBFE94ED-2423-454F-8301-089078DA325AQ37206899-82BDEEBC-ECCD-4D28-BC29-66E53710AE17Q37754703-65996C3A-6A45-4106-964C-2075E5608CC7Q38366370-82906E73-3181-44F2-9290-4C9B9DD5D497Q39329300-AEFFCE2D-268B-4C87-B1AD-5E11A9831C16Q40526468-A1E79E01-1D93-4709-8DF6-B0F9C4FDDD83Q41946210-31801660-34EC-4BDF-A4B9-ACAB37A76548Q41984412-2F53578E-AF57-4A5B-BAFB-C5C243EE6A9CQ42326567-EB4817C5-A22A-4869-9C52-3191173CFF9AQ49742445-9FA5E695-5B29-4B13-A55A-7165555AF73CQ52606374-2A05042A-678F-4A90-A097-381A7477A7FAQ55072302-1E1656ED-383D-43BC-89A8-A45DEDFBC17BQ57957379-56B92F86-633A-4668-9242-408BA55AE020
P2860
Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Synovial fluid levels and seru ...... at clinically relevant doses.
@ast
Synovial fluid levels and seru ...... at clinically relevant doses.
@en
Synovial fluid levels and seru ...... at clinically relevant doses.
@nl
type
label
Synovial fluid levels and seru ...... at clinically relevant doses.
@ast
Synovial fluid levels and seru ...... at clinically relevant doses.
@en
Synovial fluid levels and seru ...... at clinically relevant doses.
@nl
prefLabel
Synovial fluid levels and seru ...... at clinically relevant doses.
@ast
Synovial fluid levels and seru ...... at clinically relevant doses.
@en
Synovial fluid levels and seru ...... at clinically relevant doses.
@nl
P2093
P2860
P356
P1476
Synovial fluid levels and seru ...... at clinically relevant doses.
@en
P2093
Anna H K Plaas
Christophe Celeste
Jean-Francois Marier
John D Sandy
Pascal Vachon
Sheila Laverty
P2860
P304
P356
10.1002/ART.20762
P577
2005-01-01T00:00:00Z